Fintel reports that on September 25, 2024, Truist Securities downgraded their outlook for Smartsheet (NYSE:SMAR) from Buy to ...

Fintel reports that on September 25, 2024, Truist Securities initiated coverage of Perspective Therapeutics (NYSEAM:CATX) ...

Truist Securities upgraded BOK Financial Corp. (NASDAQ:BOKF) to Buy from Hold on Friday as analyst Brandon King sees ...

In a report released yesterday, Brandon King from Truist Financial maintained a Hold rating on Regions Financial (RF – Research Report), ...

In a report released yesterday, Brandon King from Truist Financial maintained a Hold rating on Comerica (CMA – Research Report), with a ...

On Monday, Truist Securities upheld its Buy rating on shares of Q2 Holdings (NYSE:QTWO) with a steady price target of $78.00. The affirmation follows the announcement of a CFO transition at Q2 ...

On Monday, Truist Securities adjusted its stance on Microchip Technology (NASDAQ:MCHP) stock, shifting the rating from Buy to Hold and revising the price target downward to $80 from the previous $89.

Regeneron Pharmaceuticals is a leading biotech firm with a strong portfolio. Click here to know what justifies a Buy rating ...

Truist Securities has updated its outlook on CarMax (NYSE: NYSE:KMX), increasing the price target to $75 from the previous $70 while keeping a Hold rating on the stock. The adjustment comes after a ...

On Monday, Truist Securities increased its price target on RadNet (NASDAQ:RDNT) shares to $80.00, up from the previous target of $70.00, while maintaining a Buy rating on the stock. The firm's ...

Guardian Pharmacy Services, Inc. (“Guardian”) today announced the pricing of its upsized initial public offering of 8,000,000 shares of Class A common ...